Heather McArthur, M.D.

Heather McArthur, M.D.

  • Komen Distinguished Chair in Clinical Breast Cancer Research
  • Internal Medicine - Hematology/Oncology
  • Breast Cancer

Biography

Heather McArthur, M.D., M.P.H., FASCO, is the Clinical Director of Breast Cancer and Komen Distinguished Chair in Clinical Breast Cancer Research at University of Texas Southwestern (UTSW) Medical Center. Dr. McArthur is a medical oncologist with a clinical practice dedicated to the care of patients with breast cancer. Her research activities are focused on innovations in the diagnosis and treatment of breast cancer, with a particular interest in novel immune therapy strategies. For example, she is currently evaluating the impact of tumor destruction with freezing (cryoablation) or radiation in combination with immune stimulation for the treatment of women with early-stage breast cancer. It is hoped that by augmenting one's immune response to the unique biologic features of one's tumor, that an affected individual may develop long-term immunity against their tumor, and thus, be cured.

Dr. McArthur completed formal medical oncology training in Canada where she was awarded a highly competitive grant that funded an advanced clinical breast cancer research fellowship at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. Thereafter, she joined MSKCC as faculty where she developed the institutional breast cancer immunotherapy (IO) program before joining Cedars Sinai Medical Center in Los Angeles in 2016 and UTSW in 2021. She has a master’s in Public Health with a focus in clinical trial design from Harvard University and has mentored many medical students, residents, fellows, and junior faculty in the conduct and reporting of studies – two of which directly informed National Comprehensive Cancer Network treatment guidelines.

Dr. McArthur has held several leadership positions in the field including Co-Chair of a Breast International Group Immunotherapy Taskforce, member of the NCI Breast Cancer IO Task Force, member of the Alliance for Clinical Trials in Oncology IO Working Group, member of several Annual Meeting Scientific Committees (ASCO, SABCS, and ESMO Breast). She has served ASCO on grant selection committees, the Breast Cancer Symposium Program Committee, as chair of the Annual Meeting IO Scientific Program Committee, as grant workshop faculty for the Annual Meeting, as member of the Annual Meeting Education Committee, as co-Chair of the Practice Health Task Force, as member of the Clinical Practice Committee and as member of an Expert Guideline Panel. She has designed, completed, and reported on many investigator-initiated studies of IO in breast cancer. She currently serves on numerous Phase III study steering committees and is the global PI or co-PI for four randomized Phase III studies of curative intent IO for the treatment of breast cancer (TROPION-Breast04, TroFuse012, IMpassion030, and Checkmate7FL).

Education & Training

  • Other Post Graduate Training - Harvard University (2006-2008)
  • Medical School - University of Toronto (1997-2001)
  • Residency - University of Calgary (2001-2004), Internal Medicine
  • Fellowship - British Columbia Cancer Vancouver Centre (2004-2006), Medical Oncology
  • Graduate School - Harvard University School of Public Health (2006-2008)

Professional Associations & Affiliations

  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • Southwest Oncology Group

Honors & Awards

  • Bernard Lee Schwartz Cancer Lectureship 2021, Scripps MD Anderson Cancer Center
  • Certificate of Excellence in Recognition of Being in the Top 10% Nationally in Patient Experience Performance of all Physicians in Specialty 2020-2021, Cedars-Sinai Medical Center
  • LA Goes Pink Award in Tribute to Liz Smagala Tate 2018-2020, Breast Cancer Research Foundation
  • Nominee, “Woman Oncologist of the Year” Award 2020, Women Leaders in Oncology
  • Robert L. Longmire Lectureship 2020, Scripps MD Anderson Cancer Center
  • American Society of Clinical Oncology (ASCO) Advocacy Program, Senator’s Club Level 2019, American Society of Clinical Oncology
  • Laura Ziskin Prize in Translational Cancer Research 2019, Stand Up To Cancer
  • Eileen Dreyer Memorial Lecture Award 2015, SASS Foundation for Medical Research Inc.
  • ASCO Cancer Foundation Merit Award, 2007, 2009, American Society of Clinical Oncology
  • San Antonio Breast Cancer Symposium AstraZeneca Clinical Scholars Award 2008, San Antonio Breast Cancer Symposium
  • First Prize, Poster Award for Epidemiology and Population Research 2006, British Colombia Cancer Agency Annual Cancer Conference
  • Stefan Grzbowski Prize for Best Research Project by a Fellow 2006, University of British Columbia Department of Medicine
  • First Prize, Poster Award for Translation II – Adoption 2005, British Columbia Cancer Agency Annual Cancer Conference
  • Second Place Award for Excellence in Research 2004, Canadian Society of Internal Medicine
  • Award for Excellence in Teaching in the Clinical Clerkship 2003, University of Calgary

Books & Publications

Research

  • Breast cancer diagnosis
  • Breast cancer treatment
  • Immunotherapy for breast cancer

Clinical Focus

  • Breast Cancer

Heather Lynn McArthur, M.D., M.P.H.

Dr. McArthur talks about her approach to patient care.